Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143700 |
| CAS No | NA |
| Mol.F. | C11H13N5O2 |
| Mol.Wt. | 247.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143701 |
| CAS No | NA |
| Mol.F. | C18H22N6O6 |
| Mol.Wt. | 418.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143702 |
| CAS No | NA |
| Mol.F. | C18H18D4N6O6 |
| Mol.Wt. | 422.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143703 |
| CAS No | NA |
| Mol.F. | C24H27N9O5 |
| Mol.Wt. | 521.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143704 |
| CAS No | NA |
| Mol.F. | C22H25BrN8O2 |
| Mol.Wt. | 513.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143705 |
| CAS No | NA |
| Mol.F. | C22H26N8O2 |
| Mol.Wt. | 434.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143706 |
| CAS No | NA |
| Mol.F. | C28H32N8O6 |
| Mol.Wt. | 576.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143707 |
| CAS No | NA |
| Mol.F. | C27H33BrN8O4 |
| Mol.Wt. | 613.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143708 |
| CAS No | NA |
| Mol.F. | C6H12N2O2 |
| Mol.Wt. | 144.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143709 |
| CAS No | 89600-66-8 |
| Mol.F. | C6H10N2O |
| Mol.Wt. | 126.156 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143710 |
| CAS No | NA |
| Mol.F. | C6H10N2O2 |
| Mol.Wt. | 142.16g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143711 |
| CAS No | NA |
| Mol.F. | C13H20N6O |
| Mol.Wt. | 276.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143712 |
| CAS No | NA |
| Mol.F. | C13H20N6O |
| Mol.Wt. | 276.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143713 |
| CAS No | NA |
| Mol.F. | C15H12N2O2S |
| Mol.Wt. | 284.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143714 |
| CAS No | NA |
| Mol.F. | C52H57N15O4 |
| Mol.Wt. | 956.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143715 |
| CAS No | NA |
| Mol.F. | C15H15ClN6O5 |
| Mol.Wt. | 394.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |